FDA announces expansion of recall on blood-pressure medication


The Food and Drug Administration continues to expand its recall of blood-pressure medication.

Torrent Pharmaceuticals is recalling 60 lots of Losartan Potassium Tablets USP and 54 lots of Losartan potassium/hydrochlorothiazide tablets, USP, due to an impurity found in the medication.

Torrent hasn’t received any reports of adverse reactions related to the recall. 

Torrent is only recalling lots of losartan-containing products that contain N-Methylnitrosobutyric acid (NMBA) above the acceptable daily intake levels released by the FDA.

Losartan is used to treat hypertension and nephropathy is Type 2 diabetic patients. 

Patients taking the tablets should continue taking the medication as stopping it could cause more harm. However, they should contact their doctors or pharmacists for an alternative treatment. 

You can find more information on the recall and the medications on the FDA’s website. 

Consumers with medical questions regarding this recall or to report an adverse event can contact Torrent Pharmaceuticals Limited at:

1-800-912-9561 (live calls received 8 a.m. – 5 p.m. Eastern Time, voicemail available 24 hours/day, 7 days/week).

Late last month, Camber Pharmaceuticals also announced a nationwide recall of Losartan tablets due to potential carcinogens found in the medication. 

The company is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg and 100 mg.  

The medication is used to treat high blood pressure and congestive heart failure.

More information on that recall is listed here.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories